VRPX
Virpax Pharmaceuticals, Inc. Common Stock
VRPX
VRPX
Delisted
VRPX was delisted on the 3rd of April, 2025.
14 hedge funds and large institutions have $21.6M invested in Virpax Pharmaceuticals, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
14
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.34M | |
| 2 | +$348K | |
| 3 | +$163K | |
| 4 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
+$39K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$33.6K |
Top Sellers
| 1 | -$336K | |
| 2 | -$77K | |
| 3 | -$52K | |
| 4 |
EGM
Engineers Gate Manager
New York
|
-$40K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$39K |